Cellebrite Valuation
| CLBT Stock | USD 19.01 0.49 2.65% |
At this time, the firm appears to be undervalued. Cellebrite DI shows a prevailing Real Value of $21.6 per share. The current price of the firm is $19.01. Our model approximates the value of Cellebrite DI from analyzing the firm fundamentals such as Current Valuation of 3.54 B, return on equity of -1.53, and Profit Margin of (0.71) % as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Cellebrite's valuation include:
Price Book 11.8412 | Enterprise Value | Enterprise Value Ebitda 52.4735 | Price Sales 9.9174 | Forward PE 37.1747 |
Undervalued
Today
Please note that Cellebrite's price fluctuation is not too volatile at this time. Calculation of the real value of Cellebrite DI is based on 3 months time horizon. Increasing Cellebrite's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Cellebrite's intrinsic value may or may not be the same as its current market price of 19.01, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 19.01 | Real 21.6 | Target 23.29 | Hype 18.35 | Naive 21.24 |
The intrinsic value of Cellebrite's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Cellebrite's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Cellebrite DI helps investors to forecast how Cellebrite stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Cellebrite more accurately as focusing exclusively on Cellebrite's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Cellebrite's intrinsic value based on its ongoing forecasts of Cellebrite's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Cellebrite's closest peers.
Cellebrite Cash |
|
Cellebrite Valuation Trend
Cellebrite's real value is important for investors to make better decisions and a more accurate overall view of Cellebrite's financial worth over time. Using both Cellebrite's enterprise value as well as its market capitalization is the best way to gauge the value of the company and is usually enough for investors to make market timing conclusions.
Cellebrite Total Value Analysis
Cellebrite DI is currently forecasted to have valuation of 3.54 B with market capitalization of 3.98 B, debt of 10.97 M, and cash on hands of 142.51 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Cellebrite fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.54 B | 3.98 B | 10.97 M | 142.51 M |
Cellebrite Investor Information
About 50.0% of the company shares are held by company insiders. The company recorded a loss per share of 1.35. Cellebrite DI had not issued any dividends in recent years. Based on the measurements of operating efficiency obtained from Cellebrite's historical financial statements, Cellebrite DI may be sliding down financialy. It has an above-average chance of going through some form of financial crunch next quarter.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total Cash From Operating Activities | 67.5 M | 126.8 M |
|
|
Cellebrite Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Cellebrite has an asset utilization ratio of 58.1 percent. This implies that the Company is making $0.58 for each dollar of assets. An increasing asset utilization means that Cellebrite DI is more efficient with each dollar of assets it utilizes for everyday operations.Cellebrite Ownership Allocation
Cellebrite holds a total of 214.84 Million outstanding shares. Over half of Cellebrite's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Also note that nearly three million seventy-two thousand two hundred fifty-five invesors are currently shorting Cellebrite expressing very little confidence in its future performance.Cellebrite Profitability Analysis
The company reported the previous year's revenue of 401.2 M. Net Loss for the year was (283.01 M) with profit before overhead, payroll, taxes, and interest of 338.61 M.About Cellebrite Valuation
The stock valuation mechanism determines Cellebrite's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Cellebrite DI based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cellebrite. We calculate exposure to Cellebrite's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Cellebrite's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 338.6 M | 243.3 M | |
| Pretax Profit Margin | (0.69) | (0.65) | |
| Operating Profit Margin | 0.14 | 0.15 | |
| Net Loss | (0.71) | (0.67) | |
| Gross Profit Margin | 0.84 | 0.66 |
Cellebrite Growth Indicators
Investing in growth stocks can be very risky. If the company such as Cellebrite does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 209.5 M | |
| Quarterly Earnings Growth Y O Y | -0.769 | |
| Forward Price Earnings | 37.1747 | |
| Shares Float | 91 M |
Cellebrite Current Valuation Indicators
Cellebrite's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Cellebrite's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Cellebrite, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Cellebrite's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Cellebrite's worth.Additional Tools for Cellebrite Stock Analysis
When running Cellebrite's price analysis, check to measure Cellebrite's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellebrite is operating at the current time. Most of Cellebrite's value examination focuses on studying past and present price action to predict the probability of Cellebrite's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellebrite's price. Additionally, you may evaluate how the addition of Cellebrite to your portfolios can decrease your overall portfolio volatility.